Business Context and Reporting Period
Company: John Wiley & Sons, Inc.
Filing Type: Form 10-K (Annual Report)
Period Ended: April 30, 2004
Business Overview: A global publisher of print and electronic products serving academics, professionals, researchers, and consumers. Core segments include Professional/Trade (43% of revenue), Scientific, Technical, and Medical (STM) (37% of revenue), and Higher Education (20% of revenue). The company operates in the U.S., Europe, Asia, Australia, and Canada.
Key Financial Metrics
| Metric | Fiscal 2004 | Fiscal 2003 |
|---|---|---|
| Revenue | $923.0 million | $854.0 million |
| Operating Income | $129.4 million | $120.3 million |
| Net Income | $88.8 million | $87.3 million |
| Diluted EPS | $1.41 | $1.38 |
| Operating Margin | 14.0% | 14.1% |
| Cash Flow from Operations | $212.2 million | $169.1 million |
| Long-Term Debt | $200.0 million | $200.0 million |
| Cash & Equivalents | $82.0 million | $33.2 million |
| Working Capital | $17.6 million | ($60.8 million) |
Material Changes vs. Prior Period
- Revenue Growth: Revenue increased 8% year-over-year (5% excluding foreign currency effects), driven by strong second-half performance in Professional/Trade (U.S.) and STM (Global).
- Profitability: Operating income rose 8% to $129.4 million. Operating margin remained stable at 14.0% despite higher operating and administrative costs (up to 51.5% of revenue), which were offset by improved gross margins.
- Cash Flow: Cash flow after investing activities improved significantly to $120 million from $44 million, reflecting a 25% increase in operating cash flow and reduced capital expenditures.
- Segment Performance:
- Professional/Trade: Revenue up 6%; contribution margin improved to 27.6%.
- STM: Revenue up 6%; contribution margin improved to 48.5% due to product mix shifts toward journals.
- Higher Education: Revenue up 3%; contribution margin improved to 27.3%.
- Europe: Revenue up 13% (5% excluding FX).
- Unusual Items: Fiscal 2004 included a $3.0 million net tax benefit from the resolution of tax matters. Fiscal 2003 included a $12.0 million one-time tax benefit from a European subsidiary merger and a $2.5 million relocation charge.
Guidance, Outlook, and Risks
- Outlook: Management anticipates increased expenditures for new technologies to remain competitive. Projected spending for fiscal 2005 is approximately $70 million for product development and $30 million for property and equipment.
- Dividends: Quarterly dividend increased to $0.065 per share in July 2003.
- Stock Repurchases: The company repurchased 937,150 shares in fiscal 2004 for $26.1 million. Authorization remains for up to 3.8 million additional shares.
- Risks & Contingencies:
- Credit Risk: Concentration in top 10 book customers (25% of revenue) and reliance on journal subscription agents (22% of revenue). No single agent exceeds 7% of revenue.
- Market Risk: Exposure to foreign exchange (sterling, euros, Asian currencies) and interest rates on $200 million of variable-rate debt.
- Industry Trends: Impact of used textbook sales on Higher Education revenue; consolidation of book wholesalers and retailers.
- Tax Legislation: Potential repeal of the Extra Territorial Income (ETI) exclusion, which currently reduces the effective tax rate by 1.6%.
Investor Verification Checklist
- Verify the sustainability of the 8% revenue growth excluding foreign currency effects, particularly in the Professional/Trade segment.
- Confirm the impact of the $3.0 million tax benefit on the reported effective tax rate of 29.0% and the pro forma rate of 31.4%.
- Assess the liquidity position given the shift from negative working capital in 2003 to positive in 2004, driven largely by cash accumulation and deferred subscription revenue.
- Monitor the $200 million variable-rate debt exposure and potential interest rate fluctuations.
- Review the status of the proposed U.S. legislation regarding the ETI tax benefit repeal and its potential impact on future effective tax rates.
- Validate the creditworthiness of the top 10 book customers and journal subscription agents, which represent significant portions of revenue and receivables.